Skip to content

Cicatrix Cream in Post Surgical Scars and Epidermic Burn

Effect the Cicatrix Cream in in Treatment of Post Surgical Scars and and Epidermic Burn.

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01018589
Enrollment
100
Registered
2009-11-23
Start date
2009-09-30
Completion date
2010-12-31
Last updated
2010-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epidermic Burn, Post Surgical Scars

Keywords

Post surgical scars, Epidermic burn, Cicatrix cream

Brief summary

The purpose of the study is to assess the effect of CICATRIX (Asian Gotu Kola or Pennywort) usage in the treatment of epidermic burns or post surgical scars. The duration of this phase 2 clinical trial will be two months.

Interventions

We will be carried out the topical application of the product (Cicatrix cream) in the epidermic burns or post surgical scars by administration fo the patients twice a day during two months to a dose of 0,1 ml of cream for each cm of surface, being controlled by the specialist in biweekly consultations. To the patient will be explained the technique of the application.

Sponsors

Catalysis SL
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patient with lesions characteristic of the investigated illness. * Signed informed consent

Exclusion criteria

* Patient that refer manifestations of high sensibility to the medication or to some of the components of the product * Patient that don't want to participate in the study * Patient not very cooperative * Family responsible not very cooperative

Design outcomes

Primary

MeasureTime frame
Reduction of the areas of lesions at 2 months (end of the treatment)2 months

Secondary

MeasureTime frame
Coloration of the lesions at 2 months (end of the treatment)2 months
Adverse effects2 months

Countries

Cuba

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026